A case of bullous pemphigoid after the SARS-CoV-2 mRNA vaccine

J Eur Acad Dermatol Venereol. 2022 Jan;36(1):e13-e16. doi: 10.1111/jdv.17676. Epub 2021 Oct 5.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • Pemphigoid, Bullous*
  • SARS-CoV-2
  • Vaccines, Synthetic
  • mRNA Vaccines

Substances

  • COVID-19 Vaccines
  • Vaccines, Synthetic